Sumithra J Mandrekar, PhD

Professor, Rochester, MN, Health Sciences Research

EmailMandrekar.Sumithra@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Sumithra J Mandrekar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Finished
3 Not started

Validation of New Tumor Measurement-based Phase II Clinical Trial Endpoints
Mandrekar, S. J., Kinney, L., Kinney, L., Kinney, L. & Kinney, L.
National Cancer Institute
Project: Research project
Core A: Administrative Core
Gores, G. J., Vile, R. G., Leof, E. B., Mandrekar, S. J., Torbenson, M. & Alberts, S. R.
National Cancer Institute
Project: Research project
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
Mandrekar, S. J. & Kinney, L.
National Cancer Institute
Project: Research project
Methodology for development, validation, and use of novel endpoints in oncology
Mandrekar, S. J. & Kinney, L.
National Cancer Institute
2/1/14 → 1/31/18
Project: Research project

7818 Citations
43 Scopus h-Index
125 Article
19 Review article
6 Editorial
4 Comment/debate
More

Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary Authorships
Adjei, A. A., Ignatius Ou, S. H., Ho, C., Pujol, J. L., Mandrekar, S., Stone, E., Bezjak, A. & Camidge, D. R., May 1 2021, In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 16, 5, p. 706-708 3 p.
Research output: Contribution to journal › Editorial › peer-review
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
Larson, R. A., Mandrekar, S. J., Huebner, L. J., Sanford, B. L., Laumann, K., Geyer, S., Bloomfield, C. D., Thiede, C., Prior, T. W., Döhner, K., Marcucci, G., Voso, M. T., Klisovic, R. B., Galinsky, I., Wei, A. H., Sierra, J., Sanz, M. A., Brandwein, J. M., de Witte, T., Niederwieser, D. & 12 others, Appelbaum, F. R., Medeiros, B. C., Tallman, M. S., Krauter, J., Schlenk, R. F., Ganser, A., Serve, H., Ehninger, G., Amadori, S., Gathmann, I., Döhner, H. & Stone, R. M., 2021, (Accepted/In press) In: Leukemia.
Research output: Contribution to journal › Article › peer-review
Statistical Considerations for Subgroup Analyses
Wang, X., Piantadosi, S., Le-Rademacher, J. & Mandrekar, S. J., Mar 2021, In: Journal of Thoracic Oncology. 16, 3, p. 375-380 6 p.
Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations
Statistical Models in Clinical Studies
Matsui, S., Le-Rademacher, J. & Mandrekar, S. J., 2021, (Accepted/In press) In: Journal of Thoracic Oncology.
Research output: Contribution to journal › Article › peer-review
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
AASLD Panel of Experts on Trial Design in HCC, Jan 2021, In: Hepatology. 73, S1, p. 158-191 34 p.
Research output: Contribution to journal › Review article › peer-review

11 Scopus citations